Literature DB >> 22718074

Inflammation biomarkers in chronic hepatitis C: association with liver histopathology, HCV genotype and cryoglobulinemia.

Maria Atta1, Milena Cabral, Gilvan Santos, Raymundo Paraná, Ajax Atta.   

Abstract

OBJECTIVE: This work investigated the profile of inflammation biomarkers in patients with chronic hepatitis C and its association with liver fibrosis, hepatic necroinflammatory activity, viral genotypes and cryoglobulinemia. SUBJECTS AND METHODS: Seventy-eight untreated patients were studied. Biomarker levels were determined by immunoassays, cryoglobulinemia by cryoprecipitation and liver histopathology investigated using METAVIR scores.
RESULTS: Decreased levels of α(1)-acid glycoprotein (AGP), C3 and haptoglobin (Hp) were observed in the patients (P < 0.0001). Increased α(1)-antitrypsin (P < 0.01) and ferritin (P < 0.0001) levels were found in this group, but C-reactive protein (CRP) and C4 levels were unaltered. Alanine aminotransferase inversely correlated with Hp (P < 0.01) and AGP (P = 0.01), whereas it was directly correlated with ferritin (P < 0.05) and AGP (P < 0.0001). The levels of CRP, C3 and C4 were lower in the patients with hepatic necroinflammatory activity (P < 0.05). Patients with advanced fibrosis had low levels of Hp and AGP (P < 0.05 and P < 0.01, respectively). Neither infection with different viral genotypes nor cryoglobulinemia caused an alteration in biomarker levels.
CONCLUSION: Chronic hepatitis C virus infection alters the levels of some biomarkers, which are mainly observed in patients with liver fibrosis and hepatic necroinflammatory activity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718074     DOI: 10.1007/s00011-012-0502-2

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  30 in total

1.  Serine protease inhibitors in patients with chronic viral hepatitis.

Authors:  A N Elzouki; H Verbaan; S Lindgren; A Widell; J Carlson; S Eriksson
Journal:  J Hepatol       Date:  1997-07       Impact factor: 25.083

2.  Influence of iron on the severity of hepatic fibrosis in patients with chronic hepatitis C.

Authors:  Tsung-Jung Lin; Li-Ying Liao; Shyr-Yi Lin; Chih-Lin Lin; Ting-An Chang
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 3.  Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations.

Authors:  Domenico Sansonno; Franco Dammacco
Journal:  Lancet Infect Dis       Date:  2005-04       Impact factor: 25.071

4.  Liver iron is a surrogate marker of severe fibrosis in chronic hepatitis C.

Authors:  Dominique Guyader; Anne-Sophie Thirouard; Lars Erdtmann; Nafissa Rakba; Sylvie Jacquelinet; Hélène Danielou; Michèle Perrin; Anne-Marie Jouanolle; Pierre Brissot; Yves Deugnier
Journal:  J Hepatol       Date:  2006-11-10       Impact factor: 25.083

5.  Autoimmunity in hepatitis C virus carriers: involvement of ferritin and prolactin.

Authors:  Gabriel M Sousa; Rodrigo C Oliveira; Mariana M Pereira; Raymundo Paraná; Maria Luiza B Sousa-Atta; Ajax M Atta
Journal:  Autoimmun Rev       Date:  2010-10-14       Impact factor: 9.754

6.  Paradoxical alteration of acute-phase protein levels in patients with chronic hepatitis C treated with IFN-alpha2b.

Authors:  László Kalabay; Elemér Nemesánszky; Antal Csepregi; Mária Pusztay; Károly Dávid; Gábor Horváth; Ervin Ibrányi; László Telegdy; Alajos Pár; Adrienn Bíró; Béla Fekete; Judith Gervain; Margit Horányi; Pál Ribiczey; Mihály Csöndes; Mónika Kleiber; Szilvia Walentin; Zoltán Prohászka; George Füst
Journal:  Int Immunol       Date:  2004-01       Impact factor: 4.823

7.  Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection.

Authors:  A Gramenzi; P Andreone; E Loggi; F G Foschi; C Cursaro; M Margotti; M Biselli; M Bernardi
Journal:  J Viral Hepat       Date:  2005-09       Impact factor: 3.728

8.  [Decrease of haptoglobin serum level in patients with chronic viral hepatitis C].

Authors:  Y Bacq; Y Schillio; J F Brechot; A De Muret; F Dubois; E H Metman
Journal:  Gastroenterol Clin Biol       Date:  1993

9.  Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection.

Authors:  Mohamed A Metwally; Claudia O Zein; Nizar N Zein
Journal:  Am J Gastroenterol       Date:  2004-02       Impact factor: 10.864

10.  The natural history of hepatitis C virus (HCV) infection.

Authors:  Stephen L Chen; Timothy R Morgan
Journal:  Int J Med Sci       Date:  2006-04-01       Impact factor: 3.738

View more
  8 in total

1.  Combined detection of liver stiffness and C-reactive protein in patients with hepatitis B virus-related liver cirrhosis, with and without hepatocellular carcinoma.

Authors:  Xiao-Yan Liu; Li-Na Ma; Ting-Ting Yan; Zhen-Hui Lu; Yuan-Yuan Tang; Xia Luo; Xiang-Chun Ding
Journal:  Mol Clin Oncol       Date:  2016-01-26

2.  Study of serum haptoglobin level and its relation to erythropoietic activity in Beta thalassemia children.

Authors:  Seham M Ragab; Manal A Safan; Eman A Badr
Journal:  Mediterr J Hematol Infect Dis       Date:  2015-02-15       Impact factor: 2.576

3.  Comparative salivary proteome of hepatitis B- and C-infected patients.

Authors:  Lorena Da Rós Gonçalves; Isabele Batista Campanhon; Romênia R Domingues; Adriana F Paes Leme; Márcia Regina Soares da Silva
Journal:  PLoS One       Date:  2014-11-25       Impact factor: 3.240

4.  Assessment of high-sensitivity C-reactive protein tests for the diagnosis of hepatocellular carcinoma in patients with hepatitis B-associated liver cirrhosis.

Authors:  Li-Na Ma; Xiao-Yan Liu; Zhen-Hui Lu; Li-Gang Wu; Yuan-Yuan Tang; Xia Luo; Yan-Chao Hu; Ting-Ting Yan; Qi Wang; Xiang-Chun Ding; Yan Xie
Journal:  Oncol Lett       Date:  2017-03-22       Impact factor: 2.967

5.  Serum C-reactive protein predicts early mortality in hospitalized patients with HBV-related decompensated cirrhosis.

Authors:  ShaoMing Zhu; Yulituzi Waili; XiaoTing Qi; YueMei Chen; YuFeng Lou; Bo Chen
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

6.  Orosomucoid in liver diseases.

Authors:  Gulsum Ozlem Elpek
Journal:  World J Gastroenterol       Date:  2021-12-07       Impact factor: 5.742

Review 7.  Review of Serum Biomarkers and Models Derived from Them in HBV-Related Liver Diseases.

Authors:  JianPing Wu; WeiLin Mao
Journal:  Dis Markers       Date:  2020-07-21       Impact factor: 3.434

8.  Serum levels of immunoglobulin free light chains in patients with chronic hepatitis C presenting cryoglobulinemia.

Authors:  Isabela S Oliveira; Milena S Cabral; Larissa S Jesus; Raymundo Paraná; Ajax M Atta; Maria Luiza B Sousa Atta
Journal:  Braz J Infect Dis       Date:  2014-09-01       Impact factor: 3.257

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.